BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33314017)

  • 1. Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities.
    Gailllard B; Cornillet-Lefebvre P; Le QH; Maloum K; Pannetier M; Lecoq-Lafon C; Grange B; Jondreville L; Michaux L; Nadal N; Ittel A; Luquet I; Struski S; Lefebvre C; Gaillard JB; Lafage-Pochitaloff M; Balducci E; Penther D; Barin C; Collonge-Rame MA; Jimenez-Poquet M; Richebourg S; Lemaire P; Defasque S; Radford-Weiss I; Bidet A; Susin SA; Nguyen-Khac F; Chapiro E;
    Br J Haematol; 2021 Apr; 193(1):72-82. PubMed ID: 33314017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma.
    Streubel B; Lamprecht A; Dierlamm J; Cerroni L; Stolte M; Ott G; Raderer M; Chott A
    Blood; 2003 Mar; 101(6):2335-9. PubMed ID: 12406890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
    Salido M; Baró C; Oscier D; Stamatopoulos K; Dierlamm J; Matutes E; Traverse-Glehen A; Berger F; Felman P; Thieblemont C; Gesk S; Athanasiadou A; Davis Z; Gardiner A; Milla F; Ferrer A; Mollejo M; Calasanz MJ; Florensa L; Espinet B; Luño E; Wlodarska I; Verhoef G; García-Granero M; Salar A; Papadaki T; Serrano S; Piris MA; Solé F
    Blood; 2010 Sep; 116(9):1479-88. PubMed ID: 20479288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of CD5-positive splenic marginal zone lymphoma with leukemic manifestation ; clinical, flow cytometry, and histopathological findings of 11 cases.
    Kojima M; Sato E; Oshimi K; Murase T; Koike T; Tsunoda S; Matsumoto T; Marutsuka K; Ogiya D; Moriuchi M; Tokunaka M; Yara Kikuti Y; Kikuchi T; Nakamura N; Ando K
    J Clin Exp Hematop; 2010; 50(2):107-12. PubMed ID: 21123968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A marginal zone phenotype in follicular lymphoma with t(14;18) is associated with secondary cytogenetic aberrations typical of marginal zone lymphoma.
    Torlakovic EE; Aamot HV; Heim S
    J Pathol; 2006 Jun; 209(2):258-64. PubMed ID: 16583359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma.
    Streubel B; Vinatzer U; Lamprecht A; Raderer M; Chott A
    Leukemia; 2005 Apr; 19(4):652-8. PubMed ID: 15703784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T(14;18)(q32;q21) involving MALT1 and IGH genes occurs in extranodal diffuse large B-cell lymphomas of the breast and testis.
    Kuper-Hommel MJ; Schreuder MI; Gemmink AH; van Krieken JH
    Mod Pathol; 2013 Mar; 26(3):421-7. PubMed ID: 23018871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a t(2;7) translocation linking CDK6 to the IGK locus in CD5(-) monoclonal B-cell lymphocytosis.
    Parker E; Macdonald JR; Wang C
    Cancer Genet; 2011 May; 204(5):260-4. PubMed ID: 21665179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. t(11;18)(q21;q21) in extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue in stomach: a study of 48 cases.
    Wang G; Auerbach A; Wei M; Dow N; Barry TS; Hodge L; Schaffer D; Sobin LH; Aguilera NS
    Mod Pathol; 2009 Jan; 22(1):79-86. PubMed ID: 18820661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary nodal marginal zone lymphomas of splenic and MALT type.
    Campo E; Miquel R; Krenacs L; Sorbara L; Raffeld M; Jaffe ES
    Am J Surg Pathol; 1999 Jan; 23(1):59-68. PubMed ID: 9888704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation t(2;7)(p11;q21) associated with the CDK6/IGK rearrangement is a rare but recurrent abnormality in B-cell lymphoproliferative malignancies.
    Douet-Guilbert N; Tous C; Le Flahec G; Bovo C; Le Bris MJ; Basinko A; Morel F; De Braekeleer M
    Cancer Genet; 2014 Mar; 207(3):83-6. PubMed ID: 24726269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma.
    Schreuder MI; Hoefnagel JJ; Jansen PM; van Krieken JH; Willemze R; Hebeda KM
    J Pathol; 2005 Feb; 205(3):302-10. PubMed ID: 15682432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous marginal zone B-cell lymphoma may exhibit both the t(14;18)(q32;q21) IGH/BCL2 and the t(14;18)(q32;q21) IGH/MALT1 translocation: an indicator for clonal transformation towards higher-grade B-cell lymphoma?
    Palmedo G; Hantschke M; Rütten A; Mentzel T; Kempf W; Tomasini D; Kutzner H
    Am J Dermatopathol; 2007 Jun; 29(3):231-6. PubMed ID: 17519619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal zone lymphomas.
    Zucca E; Rossi D; Bertoni F
    Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
    Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
    Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations].
    Dong LN; Liu HG; Jin HS; Ye HT; Gao ZF; Zhou XG; Dong GH; Zhang DD; Gong LP
    Zhonghua Bing Li Xue Za Zhi; 2008 Dec; 37(12):809-14. PubMed ID: 19159526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.